MedTech News
CMS grants NCD for renal denervation, benefiting Medtronic, Recor
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.
FastWave Medical reports first-in-human findings for Sola laser IVL system
FastWave Medical today announced new first-in-human and pre-clinical data for its Sola coronary laser intravascular lithotripsy (L-IVL) system.
FDA Grants Clearance for the First-Ever Technology to Measure “Internal” Mobility in Teeth — Generally Associated with Cracks and Loose Restorations
REDMOND, Wash., Oct. 28, 2025 /PRNewswire/ — Perimetrics, Inc., a dental technology company pioneering quantitative diagnostics, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for the InnerView® System — the first FDA-cleared technology designed to measure both internal and external mobility in teeth and implants.
AI models help pinpoint key neoantigens for personalized skin cancer vaccines
In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that contain features of good candidates for a vaccine.
New clinical tool can measure severity of debilitating skin disorders
A new clinical tool may improve how physicians assess the severity of a painful and often debilitating skin disorder, according to a study recently published in JAMA Dermatology.
Light-based tool continuously monitors vaccine quality during production
A team of researchers at Purdue University and Merck & Co. Inc., known as Merck Sharp & Dohme Corp. outside of the U.S. and Canada, has now introduced a new analytical tool that could help pharmaceutical companies boost vaccine production with rapid monitoring and analysis.
Custom-designed protein receptors help T cells target solid tumors more effectively
Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, especially those equipped with chimeric antigen receptors (CAR-T cells), have revolutionized cancer treatment. But while they’ve delivered impressive results against certain blood cancers, they’ve struggled to make an impact in solid tumors, such as those in the breast, lung, and prostate.
Integrated platform enables precise production of human neural circuits in the lab
Researchers at the Eye Clinic of the University Hospital Bonn (UKB) and the University of Bonn, together with colleagues from the University of Münster and Harvard Medical School, have developed an innovative platform that allows the function of neural networks to be studied in a targeted manner.